---
schema_version: "secwatch.filing_event.v1"
accession: "0001737287-23-000028"
form_type: "8-K"
ticker: "ALLO"
cik: "0001737287"
company_name: "Allogene Therapeutics, Inc."
filed_at: "2023-04-20T23:59:59+00:00"
generated_at: "2026-06-16T22:38:15.001752+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Allogene CTO Alison Moore resigns; Tim Moore appointed as replacement

## Summary
- Alison Moore resigns as Chief Technical Officer effective April 28, 2023 to pursue other opportunities.
- Board appoints Tim Moore as CTO effective April 24, 2023; he will also provide transitional consulting.
- No further details on reasons for departure or consulting terms were disclosed.

## SEC filing metadata
- accession: 0001737287-23-000028
- form_type: 8-K
- ticker: ALLO
- cik: 0001737287
- company_name: Allogene Therapeutics, Inc.
- filed_at: 2023-04-20T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1737287/000173728723000028/0001737287-23-000028-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1737287/000173728723000028/allo-20230418.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001737287-23-000028
- JSON: https://secwatch.observer/filing/0001737287-23-000028.json
- Plain text: https://secwatch.observer/filing/0001737287-23-000028.txt

## Key facts
- Executive change
  Tim Moore was appointed as Chief Technical Officer at Allogene Therapeutics, Inc..
  - Action: appointed
  - Role: Chief Technical Officer
  source text: On April 19, 2023, the Company’s Board of Directors appointed Tim Moore to serve as Chief Technical Officer, effective April 24, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1737287/000173728723000028/0001737287-23-000028-index.htm
- Executive change
  Alison Moore resigned as Chief Technical Officer at Allogene Therapeutics, Inc..
  - Action: resigned
  - Role: Chief Technical Officer
  source text: On April 18, 2023, Alison Moore, the Chief Technical Officer of Allogene Therapeutics, Inc. (the “Company”), notified the Company of her decision to resign effective April 28, 2023 to pursue other opportunities.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1737287/000173728723000028/0001737287-23-000028-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.